We are the CRISPR and Gene Therapy of the Microbiome company! Precision killing of bacteria has the impact to revolutionise the management of untreatable and difficult-to-treat infections as well as complex diseases directly impacted by the human microbiota. Our mission is to develop CRISPR-based medicines that give hope for effective and safe treatment of difficult-to-treat diseases in the future.
Eksternt link til SNIPR Biome - A CRISPR Company
Lersø Parkallé
Copenhagen, Capital Region, DK
SNIPR Biome - A CRISPR Company genopslog dette
Biotech R&D Leader in Synthetic Biology, Drug Discovery and Bioinformatics - Innovative Team Builder - Founder ODity.bio
Seven days to #BioEurope! Reach out if you are at #BioEurope and want to know more about SNIPR Biome - A CRISPR Company’s progress in AMR and Microbial Gene Therapy.
On November 7 and 8, Jakob Haaber will be joining a Round Table discussion at "The Empty Pipeline" conference in Strasbourg, France. This event will explore the critical question of why antibiotic innovation has slowed down and how we can address the challenges of restarting the antibiotic drug pipeline and the role of SNIPR001. Looking forward to the insights Jakob Haaber will share on this important topic! Thanks to the organizers University College Dublin - CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS - University of Oslo - University of Copenhagen (Københavns Universitet) - University of Strasbourg and funded by the Norges forskningsråd
🧬 New publication alert! Our team at SNIPR Biome - A CRISPR Company has just published a new research article on advancing bacteriophage engineering in the Open Access journal OUP Synthetic Biology. Congratulations to authors Camilla Schoopp Kristensen, Anders Østergaard Petersen, Mogens Kilstrup (DTU Bioengineering), Eric van der Helm & Adam Takos and the whole SNIPR Biome team for their excellent teamwork! Thanks to the Innovation Fund Denmark for partly funding this work. Link to the full article below 👇
SNIPR Biome - A CRISPR Company is attending #BIOEurope! Join Christian Groendahl and Eric van der Helm in Stockholm, Sweden, November 4–6, 2024, to connect and celebrate the event's 30th anniversary. Reach out via the partnering platform or partnering@sniprbiome.com to schedule a meeting!
Are you a student studying a bachelor within biotechnology, chemistry, life sciences or a similar field? Then we have an exciting opportunity to join SNIPR Biome - A CRISPR Company as a student 10-15 hours per week within lab maintenance. Please, share with your network or apply yourself: https://lnkd.in/dKik_cbk
We are pleased to share that SNIPR Biome has received funding from the Bill & Melinda Gates Foundation to advance our microbial gene therapy platform aimed at improving Environmental Enteric Dysfunction in pregnant women from low- and middle-income countries (LMICs). Environmental Enteric Dysfunction (EED), characterized by chronic inflammation of the small intestine due to entero-pathogens, leads to poor nutrient absorption and can negatively impact fetal development. Our innovative CRISPR-armed phages (CAPs) have the potential to reduce gut entero-pathogen burden and improve pregnancy outcomes in these regions. This collaboration will enable us to leverage our extensive phage library and CRISPR-armed phage cocktail (SNIPR001) to target E. coli and K. pneumoniae strains sourced from LMICs. Christian Groendahl, CEO and Co-founder, expressed his gratitude: “Receiving funding from the Gates Foundation is a strong endorsement of SNIPR Biome’s ability to improve global health and make our products available in both developed and developing countries.” Read full press release below 👇 https://lnkd.in/dBuZaK5k
Exciting opportunity to join SNIPR Biome - A CRISPR Company. We're #hiring a new Research Assistant. Please, share with your network or apply yourself
SNIPR Biome - A CRISPR Company genopslog dette
INNOVATION DISTRICT COMPANY PORTRAIT... #CRISPR is a technology so cutting edge, that companies working with it need to recruit skilled labour from around the globe. SNIPR Biome - A CRISPR Company is working to trick our gut-bacteria into producing the medication we need... Right in our intestines. To get the staff they need, they actively use their location in Copenhagen Science City as a selling point during recruitment. Read more about the company and how they recruit, here... #InnovationCPH #StartupCPH #DKlifescience Perhaps this is interesting to teams in your communities Symbion Community, COBIS - Copenhagen Bio Science Park, BioInnovation Institute, KU Lighthouse, BETA.HEALTH® – An innovation platform sponsored by the Novo Nordisk Foundation, The Pipeline, UCPH, CPHLabs, Nordic BioVentures, Accelerace, BioMedical Design Novo Nordisk Foundation Fellowship Programme
SNIPR Biome's strategic location in Copenhagen Science City gives us a competitive edge in attracting top scientific talent, thanks to its strong ecosystem and proximity to world-class institutions. Read the whole interview with CEO Christian Groendahl below👇 #CopenhagenScienceCity https://lnkd.in/dSZnnkFu